A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer
A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Despite evidence indicating the dominance of cell-of-origin signatures in molecular tumor patterns, translating these genome-wide patterns into actionable insights has been challenging. This study introduces breast cancer cell-of-origin signatures that offer significant prognostic value across all breast cancer subtypes and various clinical cohorts...
Alternative Titles
Full title
A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8a2eb70994dd4c63a4786f5a0770dfac
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a2eb70994dd4c63a4786f5a0770dfac
Other Identifiers
ISSN
1465-542X,1465-5411
E-ISSN
1465-542X
DOI
10.1186/s13058-024-01876-9
